Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ELI LILLY AND COMPANY

(LLY)
  Report
Delayed Nyse  -  04:03 2022-12-06 pm EST
368.54 USD   -0.20%
12/06Eli Lilly Says Follow-up Data from Phase 3 Verzenio Trial Show Continued Increase in Survival in Breast Cancer Patients
MT
12/06Major Pharma Companies to Remain Defensive Through at least H1 2023 Amid M&As, New Products Focus, Morgan Stanley Says
MT
12/06Credit Suisse Raises Eli Lilly's Price Target to $400 From $395, Keeps Outperform Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analysis
Pharmaceutical companies still have the upper hand
This old stock still has a lot of potential. Eli Lilly and Co. is one of the oldest companies in the United States and one of the global leader in the pharmaceutical industry. After facing more than...
More Must read
Stock Trading Strategies
ELI LILLY AND COMPANY - 03/29
The trend should regain control
BUY
More Stock Trading Analysis
Upcoming event on ELI LILLY AND COMPANY